Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an ...

📅 20/04/2026 12:02 📰 newspressnow 👁️ 12 lectures 🌍 États-Unis 📂 Science

Second candidate from Tenvie’s product engine to enter clinical development